|
1
|
Ostrom QT, Gittleman H, Fulop J, Liu M,
Blanda R, Kromer C, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the united states in 2008–2012. Neuro Oncol.
17(Suppl 4): iv1–iv62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malemud CJ: Matrix metalloproteinases
(MMPs) in health and disease: An overview. Front Biosci.
11:1696–1701. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu L, Wu J, Ying Z, Chen B, Han A, Liang
Y, Song L, Yuan J, Li J and Li M: Astrocyte elevated gene-1
upregulates matrix metalloproteinase-9 and induces human glioma
invasion. Cancer Res. 70:3750–3759. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Li Y, Li C, Yu K and Wang Q:
Increased expression of matrix metalloproteinase-13 in glioma is
associated with poor overall survival of patients. Med Oncol.
29:2432–2437. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Yuan J, Tu Y, Mao X, He S, Fu G,
Zong J and Zhang Y: Co-expression of MMP-14 and MMP-19 predicts
poor survival in human glioma. Clin Transl Oncol. 15:139–145. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Zhang K, Chen X, Zhao C and Sun Z:
Epilysin is overexpressed in glioblastoma and related to clinical
outcome of patients. Med Oncol. 32:3632015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park HI, Ni J, Gerkema FE, Liu D,
Belozerov VE and Sang QX: Identification and characterization of
human endometase (matrix metalloproteinase-26) from endometrial
tumor. J Biol Chem. 275:20540–20544. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Uria JA and López-Otin C: Matrilysin-2, a
new matrix metalloproteinase expressed in human tumors and showing
the minimal domain organization required for secretion, latency,
and activity. Cancer Res. 60:4745–4751. 2000.PubMed/NCBI
|
|
12
|
de Coignac AB, Elson G, Delneste Y,
Magistrelli G, Jeannin P, Aubry JP, Berthier O, Schmitt D, Bonnefoy
JY and Gauchat JF: Cloning of MMP-26. A novel matrilysin-like
proteinase. Eur J Biochem. 267:3323–3329. 2000.
|
|
13
|
Marchenko GN, Ratnikov BI, Rozanov DV,
Godzik A, Deryugina EI and Strongin AY: Characterization of matrix
metalloproteinase-26, a novel metalloproteinase widely expressed in
cancer cells of epithelial origin. Biochem J. 356:705–718. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng Y, Li W and Li Y, Yang H, Xu H, Liang
S, Zhang L and Li Y: Expression of Matrix Metalloproteinase-26
promotes human glioma U251 cell invasion in vitro and in vivo.
Oncol Rep. 23:69–78. 2010.PubMed/NCBI
|
|
15
|
Hu Q, Yan C, Xu C, Yan H, Qing L, Pu Y, He
Z and Li X: Matrilysin-2 expression in colorectal cancer is
associated with overall survival of patients. Tumour Biol.
35:3569–3574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang SM, Butowski NA, Sneed PK and Garner
IV: Standard treatment and experimental targeted drug therapy for
recurrent glioblastoma multiforme. Neurosurg Focus.
20:E42006.PubMed/NCBI
|
|
17
|
Bister V, Skoog T, Virolainen S, Kiviluoto
T, Puolakkainen P and Saarialho-Kere U: Increased expression of
matrix metalloproteinases-21 and −26 and TIMP-4 in pancreatic
adenocarcinoma. Mod Pathol. 20:1128–1140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li L, Mei TH, Zhou XD and Zhang XG:
Expression and clinical significance of matrix metalloproteinase
(MMP)-26 protein in non-small cell lung cancer. Ai Zhengr.
28:60–63. 2009.
|
|
19
|
Yang H, Wang Y, Li Y, Zhang L, Deng Y, Qi
D, Li Y and Li W: Roles of matrix metalloproteinase-26 in the
growth, invasion and angiogenesis of breast cancer. Oncol Lett.
4:832–836. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto H, Vinitketkumnuen A, Adachi Y,
Taniguchi H, Hirata T, Miyamoto N, Nosho K, Imsumran A, Fujita M,
Hosokawa M, et al: Association of matrilysin-2 (MMP-26) expression
with tumor progression and activation of MMP-9 in esophageal
squamous cell carcinoma. Carcinogenesis. 25:2353–2360. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao YG, Xiao AZ, Newcomer RG, Park HI,
Kang T, Chung LW, Swanson MG, Zhau HE, Kurhanewicz J and Sang QX:
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes
invasion of human prostate cancer cells. J Biol Chem.
278:15056–15064. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang J, Cao YJ, Zhao YG, Sang QX and Duan
EK: Expression of matrix metalloproteinase-26 and tissue inhibitor
of metalloproteinase-4 in human normal cytotrophoblast cells and a
choriocarcinoma cell line, JEG-3. Mol Hum Reprod. 8:659–666. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao YQ, Wang QY, Zhai M, Xu J, Chen XQ,
Liu WL, Zhang M, Song SJ, Wang JM, Meng FY and Shan YD: A
multi-center clinical trial of recombinant human thrombopoietin in
chronic refractory idiopathic thrombocytopenic purpura. Zhonghua
Nei Ke Za Zhi. 43:608–610. 2004.(In Chinese). PubMed/NCBI
|
|
24
|
Lee S, Desai KK, Iczkowski KA, Newcomer
RG, Wu KJ, Zhao YG, Tan WW, Roycik MD and Sang QX: Coordinated peak
expression of MMP-26 and TIMP-4 in preinvasive human prostate
tumor. Cell Res. 16:750–758. 2006. View Article : Google Scholar : PubMed/NCBI
|
